Needham & Company Maintains a 'Hold' on Cutera (CUTR); Very Good Quarter on the Strength of New Products
Tweet
Share
E-mailGet Alerts CUTR Hot Sheet
Price: $0.10 --0%
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Needham & Company maintains a 'Hold' on Cutera (NASDAQ: CUTR).
Needham analyst says, "CUTR had a very good quarter primarily on the strength of new products, especially its GenesisPlus, which was recently cleared in the U.S. and Canada to treat toe fungus. The device represented 58% of North American orders taken in the quarter and could drive a return to sustained growth for the company."
For more ratings news on Cutera click here and for the rating history of Cutera click here.
Shares of Cutera closed at $8.22 yesterday.
Needham analyst says, "CUTR had a very good quarter primarily on the strength of new products, especially its GenesisPlus, which was recently cleared in the U.S. and Canada to treat toe fungus. The device represented 58% of North American orders taken in the quarter and could drive a return to sustained growth for the company."
For more ratings news on Cutera click here and for the rating history of Cutera click here.
Shares of Cutera closed at $8.22 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Coherent (COHR) PT Raised to $420 at Needham
- Needham Reiterates Buy Rating on Lucid Diagnostics Inc (LUCD)
- Needham Reiterates Buy Rating on Cerebras Systems (CBRS)
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Needham & CompanySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
